Tobacco makers join race to develop Covid-19 vaccine

April 01
15:04 2020

The maker of Lucky Strike and Camel cigarettes has entered the fray of companies trying to develop a vaccine against Covid-19, hoping to produce up to 3m doses a week in two months time. British American Tobacco on Wednesday said its subsidiary Kentucky BioProcessing was using “proprietary, fast-growing tobacco plant technology” in pre-clinical testing on animals, making it one of more than 20 companies and public sector organisations worldwide racing to develop a vaccine. The company said it had cloned a portion of the genetic sequence of the virus and developed a potential antigen, which induces the production of antibodies and boosts the body’s immune system.

Related Articles